These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 27143722
1. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity. Yeh SC, Wang PY, Lou YW, Khoo KH, Hsiao M, Hsu TL, Wong CH. Proc Natl Acad Sci U S A; 2016 May 17; 113(20):5592-7. PubMed ID: 27143722 [Abstract] [Full Text] [Related]
2. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, Huang PI, Chen MT. J Chin Med Assoc; 2016 Oct 17; 79(10):538-45. PubMed ID: 27530866 [Abstract] [Full Text] [Related]
3. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP, Prado MB, Cruz L, Martins VR, Santos TG, Lopes MH. Stem Cell Res Ther; 2017 Apr 17; 8(1):76. PubMed ID: 28412969 [Abstract] [Full Text] [Related]
8. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays. Nie S, Gurrea M, Zhu J, Thakolwiboon S, Heth JA, Muraszko KM, Fan X, Lubman DM. J Proteome Res; 2015 Feb 06; 14(2):814-22. PubMed ID: 25469866 [Abstract] [Full Text] [Related]
9. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells. Motegi H, Kamoshima Y, Terasaka S, Kobayashi H, Houkin K. Neuropathology; 2014 Aug 06; 34(4):378-85. PubMed ID: 24673436 [Abstract] [Full Text] [Related]
10. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V. Cell Biol Int; 2012 Jan 06; 36(1):29-38. PubMed ID: 21916848 [Abstract] [Full Text] [Related]
11. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells. Kwon KM, Chung TW, Kwak CH, Choi HJ, Kim KW, Ha SH, Cho SH, Lee YC, Ha KT, Lee MJ, Kim CH. Int J Biol Sci; 2017 Jan 06; 13(3):265-275. PubMed ID: 28367091 [Abstract] [Full Text] [Related]
12. Sialidase NEU4 is involved in glioblastoma stem cell survival. Silvestri I, Testa F, Zappasodi R, Cairo CW, Zhang Y, Lupo B, Galli R, Di Nicola M, Venerando B, Tringali C. Cell Death Dis; 2014 Aug 21; 5(8):e1381. PubMed ID: 25144716 [Abstract] [Full Text] [Related]
13. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity. Sun P, Xia S, Lal B, Shi X, Yang KS, Watkins PA, Laterra J. BMC Cancer; 2014 Jun 04; 14():401. PubMed ID: 24893952 [Abstract] [Full Text] [Related]
17. Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling. Kim B, Jung N, Lee S, Sohng JK, Jung HJ. Phytother Res; 2016 Nov 04; 30(11):1833-1840. PubMed ID: 27468969 [Abstract] [Full Text] [Related]
18. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction. Guo H, Liu C, Yang L, Dong L, Wang L, Wang Q, Li H, Zhang J, Lin P, Wang X. Mol Carcinog; 2016 Jan 04; 55(1):77-89. PubMed ID: 25557841 [Abstract] [Full Text] [Related]
19. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ. Stem Cells; 2011 Mar 04; 29(3):452-61. PubMed ID: 21425408 [Abstract] [Full Text] [Related]
20. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, Forsyth P, Auer RN, Dunn JF, Cairncross JG, Parney IF, Weiss S. Stem Cells; 2009 Aug 04; 27(8):1722-33. PubMed ID: 19544433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]